Keywords: ارزیابی جهانی پزشک; dose escalation; dose optimization; psoriasis; secukinumab; AE; adverse event; PASI; Psoriasis Area and Severity Index; PASI-75; 75% reduction from baseline PASI score; PGA; Physician Global Assessment;
مقالات ISI ارزیابی جهانی پزشک (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ارزیابی جهانی پزشک; guttate psoriasis; HLA-C*06:02; psoriasis; ustekinumab; BSA; body surface area; HLA; human leukocyte antigen; IL; interleukin; PGA; physician global assessment; Th; T helper;
Keywords: ارزیابی جهانی پزشک; Disease Activity; Self-monitoring; Golimumab; PURSUIT; CCR; continuous clinical response; CRP; C-reactive protein; IBD; inflammatory bowel disease; IBDQ; inflammatory bowel disease questionnaire; PGA; physician global assessment; PROMIS; Patient Reported
Keywords: ارزیابی جهانی پزشک; clinical subtypes; hidradenitis suppurativa; Hurley staging; inflammatory; noninflammatory; Physician Global Assessment; Sartorius score; severity
Keywords: ارزیابی جهانی پزشک; CD; Crohn's disease; IBD; Inflammatory bowel disease; IBD-U; IBD-unclassified; IL; Interleukin; PGA; Physician global assessment; PIBDCRG; Pediatric Inflammatory Bowel Disease Collaborative Research Group; UC; Ulcerative colitis; VEO; Very early-onset;
Keywords: ارزیابی جهانی پزشک; CL; checklist; GiECAT; Gastrointestinal Endoscopy Competency Assessment Tool; GRS; global rating scale; ICC; intraclass correlation coefficient; PGA; physician global assessment;
Keywords: ارزیابی جهانی پزشک; assessment tool; nail psoriasis; Nail Psoriasis Severity Index; Nijmegen-Nail Psoriasis Activity Index Tool; psoriasis; scoring systems; ICC; intraclass correlation coefficient; NAPSI; Nail Psoriasis Severity Index; N-NAIL; Nijmegen-Nail psoriasis Act
Keywords: ارزیابی جهانی پزشک; biologics; combination therapy; comparative effectiveness; Dermatology Life Quality Index; Physician Global Assessment; psoriasis; quality of life; systemic treatments; BSA; body surface area; DLQI; Dermatology Life Quality Index; FDA; Food and Drug Admin
Keywords: ارزیابی جهانی پزشک; Dermatology Life Quality Index; patient-reported outcome; Physician Global Assessment; psoriasis; Psoriasis Area and Severity Index; quality of life; BSA; body surface area; CI; confidence interval; DLQI; Dermatology Life Quality Index; HRQoL; health-rela
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator-
Keywords: ارزیابی جهانی پزشک; adalimumab; efficacy; guselkumab; hand and foot psoriasis; nail psoriasis; psoriasis; safety; scalp psoriasis; VOYAGE 1; VOYAGE 2; AE; adverse event; DLQI; Dermatology Life Quality Index; f-PGA; Fingernail Physician Global Assessment; HRQoL; health-relate
Development and Initial Validation of a Questionnaire to Measure Health-Related Quality of Life of Adults with Common Variable Immune Deficiency: The CVID_QoL Questionnaire
Keywords: ارزیابی جهانی پزشک; Burden of disease; Common variable immune deficiency; CVID_QoL; Disease-specific questionnaire; Quality of life; Questionnaire validation; BMI; Body mass index; CVID; Common variable immune deficiency; EF; Emotional functioning; EQ-5D; EuroQol-5 dimension
Efficacy and safety of canakinumab in Schnitzler syndrome: AÂ multicenter randomized placebo-controlled study
Keywords: ارزیابی جهانی پزشک; Autoinflammatory; canakinumab; IL-1; Schnitzler syndrome; urticaria; CAPS; Cryopyrin-associated periodic syndrome; CRP; C-reactive protein; DLQI; Dermatology Life Quality Index; IL-1Ra; IL-1 receptor antagonist; PGA; Physician global assessment; SAA; Seru
Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical
Keywords: ارزیابی جهانی پزشک; apremilast; difficult to treat; ESTEEM; moderate to severe; palmoplantar psoriasis; palms; PSOR-005; soles; ESTEEM; Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis; IL; interleukin; m-PPPASI; modified Palmoplantar Psoriasis Are
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study
Keywords: ارزیابی جهانی پزشک; efficacy; Janus kinase inhibitor; long-term; psoriasis; randomized controlled trial; safety; tofacitinib; AE; adverse event; BID; twice daily; CI; confidence interval; HZ; herpes zoster; IR; incidence rate; LTE; long-term extension; NMSC; nonmelanoma skin
OBSERVE-5: Observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results
Keywords: ارزیابی جهانی پزشک; adverse events; etanercept; infections; malignancy; plaque psoriasis; registry; safety; surveillance; BSA; body surface area; CI; confidence interval; EMI; event of medical interest; NMSC; nonmelanoma skin cancer; PGA; physician global assessment; SAE; se
Original articleFive-year analysis from the ESPRIT 10-year postmarketing surveillance registry of adalimumab treatment for moderate to severe psoriasis
Keywords: ارزیابی جهانی پزشک; adalimumab; adverse events; long-term safety; malignancy; registry; serious infections; AE; adverse event; E/100PY; events per 100 patient-years of total adalimumab exposure; MI; myocardial infarction; PGA; Physician Global Assessment; PY; patient-years;
Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)
Keywords: ارزیابی جهانی پزشک; epidermolysis bullosa; Epidermolysis Bullosa Disease Activity and Scarring Index; outcome measure; reliability; severity score; validation; BEBS; Birmingham Epidermolysis Bullosa Severity; CI; confidence interval; EB; epidermolysis bullosa; EBDASI; Epider
Original articleA double-blind, randomized, placebo-controlled trial of adalimumab in the treatment of cutaneous sarcoidosis
Keywords: ارزیابی جهانی پزشک; adalimumab; efficacy; safety; sarcoidosis; treatment; tumor necrosis factor; AE; adverse event(s); DLQI; Dermatology Life Quality Index; FEV1; forced expiratory volume in one second; FVC; forced vital capacity; PGA; Physician Global Assessment; PGE; Patie
Endoscopic and Clinical Variables That Predict Sustained Remission in Children With Ulcerative Colitis Treated With Infliximab
Keywords: ارزیابی جهانی پزشک; Prognosis; IBD; AUROC; Predicting Response to Therapy; CI; confidence interval; CRP; C-reactive protein; IQR; interquartile range; MH; mucosal healing; PaGA; patient global assessment; PGA; physician global assessment; PUCAI; Pediatric UC Activity Index;
Product of the Physician Global Assessment and body surface area: A simple static measure of psoriasis severity in a longitudinal cohort
Keywords: ارزیابی جهانی پزشک; disease activity instrument; Physician Global Assessment; product of Physician Global Assessment and Body Surface Area; psoriasis; Psoriasis Area and Severity Index; severity measurementBSA, body surface area; GPA, Global Patient Assessment; PASI, Psorias
Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why do both? A systematic analysis of randomized controlled trials of biologic agents for moderate to severe plaque psoriasis
Keywords: ارزیابی جهانی پزشک; Physician Global Assessment; Psoriasis Area and Severity Index; psoriasis severity assessment toolsBSA, body surface area; FDA, Food and Drug Administration; PASI, Psoriasis Area and Severity Index; PASI 75, 75% reduction in Psoriasis Area and Severity In
The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis
Keywords: ارزیابی جهانی پزشک; adalimumab; biologic therapy; cost savings; disease severity; psoriasis; work productivity and activity impairment; DLQI; Dermatology Life Quality Index; PASI; Psoriasis Area and Severity Index; PGA; Physician Global Assessment; REVEAL; randomized control
Comparison of patients' and providers' severity evaluation of oral mucosal conditions
Keywords: ارزیابی جهانی پزشک; alexithymia; communication patient-provider; 14-item Oral Health Impact Profile; oral mucosal conditions; Physician Global Assessment; quality of life; severityBMS, burning mouth syndrome; GHQ-12, 12-item General Health Questionnaire; OHIP-14, 14-item Ora
Factors That Determine Risk for Surgery in Pediatric Patients With Crohn's Disease
Keywords: ارزیابی جهانی پزشک; Pediatric Crohn's Disease; Surgery; Intestinal Resection; Abscess Drainage; Penetrating; Stricture; CD; Crohn's disease; CI; confidence interval; IBD; inflammatory bowel disease; PGA; physician global assessment; PIBDCRG; Pediatric Inflammatory Bowel Dise
Diet and Rheumatoid Arthritis: A Review of the Literature
Keywords: ارزیابی جهانی پزشک; rheumatoid arthritis; diet; n-3 fatty acids; oral tolerization; AA; arachidonic acid; ALA; α-linoleic acid; APC; antigen-presenting cells; ARA; American Rheumatology Association; CO; cross over; COX; cyclooxygenase; CRP; C-reactive protein; DAS; Disease